Versor Investments LP Cuts Position in Crocs, Inc. $CROX

Versor Investments LP trimmed its holdings in shares of Crocs, Inc. (NASDAQ:CROX) by 71.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,372 shares of the textile maker’s stock after selling 8,261 shares during the quarter. Versor Investments LP’s holdings in Crocs were worth $282,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Boston Partners grew its stake in Crocs by 2,659.1% in the 2nd quarter. Boston Partners now owns 1,688,383 shares of the textile maker’s stock valued at $171,003,000 after purchasing an additional 1,627,190 shares during the period. Alliancebernstein L.P. boosted its holdings in shares of Crocs by 5.8% in the 2nd quarter. Alliancebernstein L.P. now owns 1,180,405 shares of the textile maker’s stock worth $119,551,000 after buying an additional 64,672 shares during the last quarter. LSV Asset Management grew its position in Crocs by 21.9% during the second quarter. LSV Asset Management now owns 1,073,120 shares of the textile maker’s stock valued at $108,686,000 after buying an additional 192,860 shares during the period. Thrivent Financial for Lutherans grew its position in Crocs by 4.2% during the second quarter. Thrivent Financial for Lutherans now owns 768,304 shares of the textile maker’s stock valued at $77,814,000 after buying an additional 31,083 shares during the period. Finally, Patient Capital Management LLC increased its holdings in Crocs by 17.0% during the third quarter. Patient Capital Management LLC now owns 588,794 shares of the textile maker’s stock worth $49,194,000 after buying an additional 85,416 shares during the last quarter. 93.44% of the stock is currently owned by institutional investors.

Trending Headlines about Crocs

Here are the key news stories impacting Crocs this week:

• Positive Sentiment: Q4 results beat expectations and management raised FY‑2026 EPS guidance above consensus, supporting a constructive outlook for earnings growth. Crocs, Inc. Reports Fourth Quarter and Full-Year 2025 Results; Issues First Quarter and Full-Year 2026 Outlook
• Positive Sentiment: Management repurchased 6.5M shares ($577M) in 2025 and cites strong free cash flow and debt reduction — supporting buyback-driven EPS accretion. Crocs, Inc. Reports Fourth Quarter and Full-Year 2025 Results; Issues First Quarter and Full-Year 2026 Outlook
• Positive Sentiment: Analysts have responded by raising forecasts and price targets (including a Monness Crespi & Hardt raise to $130), boosting buy-side sentiment. Crocs Analysts Boost Their Forecasts After Upbeat Q4 Results
• Neutral Sentiment: International growth and product diversification helped offset North American softness, a mixed signal for how sustainable the recovery is across channels. CROX Q4 deep dive: International growth and product diversification offset North American challenges
• Neutral Sentiment: Management’s earnings call balanced growth ambition with caution — investors must watch channel inventory actions and margin cadence through 2026. Crocs Earnings Call Balances Growth Ambition With Caution
• Neutral Sentiment: Short‑interest data in feeds shows unusual/erroneous zero values and NaN changes — noisy data may create short‑term uncertainty but doesn’t clearly indicate a rising short position.
• Negative Sentiment: Revenue was down year‑over‑year (about 3.3%) and Heydude brand sales declined materially, highlighting uneven end‑market demand and pressuring margin recovery. Crocs’ Q4 Earnings Top Estimates, Direct-to-Consumer Revenues Up 4.7%
• Negative Sentiment: After Thursday’s roughly 15–20% post‑earnings surge, some intraday weakness looks like profit‑taking and rotation; volatile swings can persist while investors reassess execution vs. expectations. Crocs Stock Soared Nearly 20% on Thursday— What Investors Need to Know

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on CROX shares. Needham & Company LLC boosted their target price on shares of Crocs from $100.00 to $118.00 and gave the company a “buy” rating in a research note on Thursday. Piper Sandler reiterated a “neutral” rating and issued a $95.00 price objective on shares of Crocs in a research note on Thursday. Monness Crespi & Hardt increased their price objective on Crocs from $100.00 to $130.00 and gave the company a “buy” rating in a report on Friday. Barclays boosted their target price on Crocs from $86.00 to $109.00 and gave the company an “equal weight” rating in a research note on Friday. Finally, UBS Group reaffirmed a “neutral” rating on shares of Crocs in a research report on Tuesday, February 3rd. Four research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $104.09.

Crocs Trading Down 1.6%

NASDAQ:CROX opened at $96.88 on Friday. Crocs, Inc. has a 1 year low of $73.21 and a 1 year high of $122.84. The stock’s fifty day moving average price is $86.81 and its two-hundred day moving average price is $84.70. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.27 and a quick ratio of 0.83. The company has a market cap of $5.03 billion, a P/E ratio of -76.89 and a beta of 1.56.

Crocs (NASDAQ:CROX) last announced its quarterly earnings results on Thursday, February 12th. The textile maker reported $2.29 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.37. The company had revenue of $957.64 million during the quarter, compared to analysts’ expectations of $916.16 million. Crocs had a positive return on equity of 45.17% and a negative net margin of 2.01%.The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the previous year, the business earned $2.52 earnings per share. Crocs has set its FY 2026 guidance at 12.880-13.350 EPS and its Q1 2026 guidance at 2.670-2.770 EPS. As a group, analysts expect that Crocs, Inc. will post 13.2 EPS for the current year.

Crocs Profile

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.